Symptomtext
medication error due to reconstituting with the wrong diluent and administering to a patient, with no reported adverse event; Initial information received on 15-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 months old female patient who experienced medication error due to reconstituting with the wrong diluent and administering to a patient, with no reported adverse event while receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP) for Prophylactic vaccination. On 14-Apr-2022, the patient received a dose of suspect HIB (PRP/T) VACCINE lot UJ574AAA via intramuscular route in unknown administration site for prophylactic vaccination. On 14-APR-2022 the patient developed a non-serious medication error due to reconstituting with the wrong diluent and administering to a patient, with no reported adverse event (medication error) following the administration of HIB (PRP/T) VACCINE. Action taken with HAEMOPHILUS TYPE B (HIB) VACCINE (ACT-HIB) was not applicable. It was not reported if the patient received a corrective treatment for the event (medication error due to reconstituting with the wrong diluent and administering to a patient, with no reported adverse event). At time of reporting, the outcome was Unknown for the event medication error due to reconstituting with the wrong diluent and administering to a patient, with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.